Please enable JavaScript to continue using this application.

Compare $ADPT vs $MRVI | Chartloom

Compare

$ADPT vs $MRVI

Adaptive Biotechnologies Corp · Maravai LifeSciences Holdings Inc

ADPT

Adaptive Biotechnologies Corp

MRVI

Maravai LifeSciences Holdings Inc

Compare $ADPT vs $MRVI

Comparing Adaptive Biotechnologies Corp and Maravai LifeSciences Holdings Inc

ADPTAdaptive Biotechnologies Corp

MRVIMaravai LifeSciences Holdings Inc

ADPTAdaptive Biotechnologies Corp

Market cap

$4.21B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.97x

Rev growth (TTM)

50.1%

YTD performance

66.5%

52W performance

70.4%

FCF yield

-0.6%

MRVIMaravai LifeSciences Holdings Inc

Market cap

$1.92B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.68x

Rev growth (TTM)

-3.3%

YTD performance

118.8%

52W performance

123.4%

FCF yield

-1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ADPT

MRVI

Detailed metrics comparison

ADPT

Adaptive Biotechnologies Corp

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

ADPT$4.21B

MRVI$1.92B

Enterprise Value

ADPT$4.38B

MRVI$2.03B

Price

ADPT$26.49

MRVI$7.44

P/E Ratio

ADPTN/A

MRVIN/A

P/S Ratio

ADPT13.68x

MRVI9.20x

EV/Sales

ADPT14.21x

MRVI9.71x

EV/EBITDA

ADPT0.00x

MRVI24.69x

P/B Ratio

ADPT31.66x

MRVI10.03x

P/FCF Ratio

ADPTN/A

MRVIN/A

EV/FCF

ADPT-182.18x

MRVI-57.75x

PEG Ratio

ADPTN/A

MRVIN/A

Forward P/E (NTM)

ADPTN/A

MRVIN/A

Forward P/S (NTM)

ADPT12.97x

MRVI8.68x

Revenue (TTM)

ADPT$308M

MRVI$209M

Revenue Growth (YoY)

ADPT50.1%

MRVI-3.3%

Forward Rev Growth

ADPT22.3%

MRVI6.5%

Gross Margin (TTM)

ADPT75.6%

MRVI34.9%

Operating Margin (TTM)

ADPT0.0%

MRVI0.0%

EBITDA Margin (TTM)

ADPT-6.7%

MRVI-10.4%

Net Margin (TTM)

ADPT-20.7%

MRVI-37.1%

FCF Margin (TTM)

ADPT-7.8%

MRVI-16.8%

Net Income (TTM)

ADPT$-64M

MRVI$-77M

FCF (TTM)

ADPT$-24M

MRVI$-35M

EPS (TTM)

ADPT-$0.40

MRVI-$0.52

ROE (TTM)

ADPT-3264.0%

MRVI-3542.0%

ROA (TTM)

ADPT-1188.0%

MRVI-1054.0%

ROIC (TTM)

ADPT-1690.0%

MRVI-1572.0%

Cash

ADPT$170M

MRVI$70M

Debt

ADPT$335M

MRVI$177M

Net Cash/Debt

ADPT$-165M

MRVI$-107M

Current Ratio (TTM)

ADPT4.79x

MRVI4.05x

Quick Ratio (TTM)

ADPT4.51x

MRVI2.63x

Debt/Equity (TTM)

ADPT2.34x

MRVI0.86x

Debt/Assets (TTM)

ADPT0.0%

MRVI0.0%

Interest Coverage (TTM)

ADPTN/A

MRVIN/A

Net Debt/EBITDA (TTM)

ADPT0.00x

MRVI0.00x

Beta

ADPT2.16

MRVI0.63

52W Performance

ADPT70.4%

MRVI123.4%

YTD Performance

ADPT66.5%

MRVI118.8%

% from 52W High

ADPT-13.8%

MRVI-21.0%

% from 52W Low

ADPT120.7%

MRVI192.3%

Asset Turnover (TTM)

ADPT0.57x

MRVI0.28x

FCF Yield (TTM)

ADPT-0.6%

MRVI-1.8%

Earnings Yield (TTM)

ADPT-1.5%

MRVI-4.0%

Dividend Yield (TTM)

ADPTN/A

MRVIN/A

Rule of 40

ADPT42.3

MRVI-20.1

EV/GP/RG

ADPT3.28

MRVI4.63

Ticker research

View ADPT research View MRVI research

Metric	ADPT Adaptive Biotechnologies Corp	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap	$4.21B	$1.92B
Enterprise Value	$4.38B	$2.03B
Price	$26.49	$7.44
P/E Ratio	N/A	N/A
P/S Ratio	13.68x	9.20x
EV/Sales	14.21x	9.71x
EV/EBITDA	0.00x	24.69x
P/B Ratio	31.66x	10.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-182.18x	-57.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.97x	8.68x
Revenue & Growth
Revenue (TTM)	$308M	$209M
Revenue Growth (YoY)	50.1%	-3.3%
Forward Rev Growth	22.3%	6.5%
Profitability
Gross Margin (TTM)	75.6%	34.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6.7%	-10.4%
Net Margin (TTM)	-20.7%	-37.1%
FCF Margin (TTM)	-7.8%	-16.8%
Net Income (TTM)	$-64M	$-77M
FCF (TTM)	$-24M	$-35M
EPS (TTM)	-$0.40	-$0.52
ROE (TTM)	-3264.0%	-3542.0%
ROA (TTM)	-1188.0%	-1054.0%
ROIC (TTM)	-1690.0%	-1572.0%
Financial Health
Cash	$170M	$70M
Debt	$335M	$177M
Net Cash/Debt	$-165M	$-107M
Current Ratio (TTM)	4.79x	4.05x
Quick Ratio (TTM)	4.51x	2.63x
Debt/Equity (TTM)	2.34x	0.86x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.16	0.63
52W Performance	70.4%	123.4%
YTD Performance	66.5%	118.8%
% from 52W High	-13.8%	-21.0%
% from 52W Low	120.7%	192.3%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.28x
FCF Yield (TTM)	-0.6%	-1.8%
Earnings Yield (TTM)	-1.5%	-4.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.3	-20.1
EV/GP/RG	3.28	4.63
Ticker research	View ADPT research	View MRVI research

Valuation

P/S Ratio

MRVI

9.20x

ADPT

13.68x

EV/FCF

ADPT

-182.18x

MRVI

-57.75x

Growth & revenue

Revenue Growth TTM

ADPT

50.1%

MRVI

-3.3%

Forward Revenue Growth

ADPT

22.3%

MRVI

6.5%

Profitability & performance

Gross Margin

ADPT

75.6%

MRVI

34.9%

ROE

ADPT

-3264.0%

MRVI

-3542.0%

FCF Yield %

ADPT

-0.6%

MRVI

-1.8%

52-Week Performance

MRVI

123.4%

ADPT

70.4%

Detailed metrics comparison

ADPT

Adaptive Biotechnologies Corp

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

ADPT$4.21B

MRVI$1.92B

Enterprise Value

ADPT$4.38B

MRVI$2.03B

Price

ADPT$26.49

MRVI$7.44

P/E Ratio

ADPTN/A

MRVIN/A

P/S Ratio

ADPT13.68x

MRVI9.20x

EV/Sales

ADPT14.21x

MRVI9.71x

EV/EBITDA

ADPT0.00x

MRVI24.69x

P/B Ratio

ADPT31.66x

MRVI10.03x

P/FCF Ratio

ADPTN/A

MRVIN/A

EV/FCF

ADPT-182.18x

MRVI-57.75x

PEG Ratio

ADPTN/A

MRVIN/A

Forward P/E (NTM)

ADPTN/A

MRVIN/A

Forward P/S (NTM)

ADPT12.97x

MRVI8.68x

Revenue (TTM)

ADPT$308M

MRVI$209M

Revenue Growth (YoY)

ADPT50.1%

MRVI-3.3%

Forward Rev Growth

ADPT22.3%

MRVI6.5%

Gross Margin (TTM)

ADPT75.6%

MRVI34.9%

Operating Margin (TTM)

ADPT0.0%

MRVI0.0%

EBITDA Margin (TTM)

ADPT-6.7%

MRVI-10.4%

Net Margin (TTM)

ADPT-20.7%

MRVI-37.1%

FCF Margin (TTM)

ADPT-7.8%

MRVI-16.8%

Net Income (TTM)

ADPT$-64M

MRVI$-77M

FCF (TTM)

ADPT$-24M

MRVI$-35M

EPS (TTM)

ADPT-$0.40

MRVI-$0.52

ROE (TTM)

ADPT-3264.0%

MRVI-3542.0%

ROA (TTM)

ADPT-1188.0%

MRVI-1054.0%

ROIC (TTM)

ADPT-1690.0%

MRVI-1572.0%

Cash

ADPT$170M

MRVI$70M

Debt

ADPT$335M

MRVI$177M

Net Cash/Debt

ADPT$-165M

MRVI$-107M

Current Ratio (TTM)

ADPT4.79x

MRVI4.05x

Quick Ratio (TTM)

ADPT4.51x

MRVI2.63x

Debt/Equity (TTM)

ADPT2.34x

MRVI0.86x

Debt/Assets (TTM)

ADPT0.0%

MRVI0.0%

Interest Coverage (TTM)

ADPTN/A

MRVIN/A

Net Debt/EBITDA (TTM)

ADPT0.00x

MRVI0.00x

Beta

ADPT2.16

MRVI0.63

52W Performance

ADPT70.4%

MRVI123.4%

YTD Performance

ADPT66.5%

MRVI118.8%

% from 52W High

ADPT-13.8%

MRVI-21.0%

% from 52W Low

ADPT120.7%

MRVI192.3%

Asset Turnover (TTM)

ADPT0.57x

MRVI0.28x

FCF Yield (TTM)

ADPT-0.6%

MRVI-1.8%

Earnings Yield (TTM)

ADPT-1.5%

MRVI-4.0%

Dividend Yield (TTM)

ADPTN/A

MRVIN/A

Rule of 40

ADPT42.3

MRVI-20.1

EV/GP/RG

ADPT3.28

MRVI4.63

Ticker research

View ADPT research View MRVI research

Metric	ADPT Adaptive Biotechnologies Corp	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap	$4.21B	$1.92B
Enterprise Value	$4.38B	$2.03B
Price	$26.49	$7.44
P/E Ratio	N/A	N/A
P/S Ratio	13.68x	9.20x
EV/Sales	14.21x	9.71x
EV/EBITDA	0.00x	24.69x
P/B Ratio	31.66x	10.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-182.18x	-57.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.97x	8.68x
Revenue & Growth
Revenue (TTM)	$308M	$209M
Revenue Growth (YoY)	50.1%	-3.3%
Forward Rev Growth	22.3%	6.5%
Profitability
Gross Margin (TTM)	75.6%	34.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6.7%	-10.4%
Net Margin (TTM)	-20.7%	-37.1%
FCF Margin (TTM)	-7.8%	-16.8%
Net Income (TTM)	$-64M	$-77M
FCF (TTM)	$-24M	$-35M
EPS (TTM)	-$0.40	-$0.52
ROE (TTM)	-3264.0%	-3542.0%
ROA (TTM)	-1188.0%	-1054.0%
ROIC (TTM)	-1690.0%	-1572.0%
Financial Health
Cash	$170M	$70M
Debt	$335M	$177M
Net Cash/Debt	$-165M	$-107M
Current Ratio (TTM)	4.79x	4.05x
Quick Ratio (TTM)	4.51x	2.63x
Debt/Equity (TTM)	2.34x	0.86x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.16	0.63
52W Performance	70.4%	123.4%
YTD Performance	66.5%	118.8%
% from 52W High	-13.8%	-21.0%
% from 52W Low	120.7%	192.3%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.28x
FCF Yield (TTM)	-0.6%	-1.8%
Earnings Yield (TTM)	-1.5%	-4.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.3	-20.1
EV/GP/RG	3.28	4.63
Ticker research	View ADPT research	View MRVI research